- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x QS0: N-[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]-4-(1-methylpyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine
- 32 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 7 residues within 4Å:- Chain A: L.83, M.86, N.87, K.94, V.98, H.99, L.100
Ligand excluded by PLIPEDO.3: 4 residues within 4Å:- Chain A: K.298, L.299, H.300, K.329
Ligand excluded by PLIPEDO.4: 7 residues within 4Å:- Chain A: Q.196, Y.197, V.208, E.242, K.266, K.269
- Chain C: N.108
Ligand excluded by PLIPEDO.5: 4 residues within 4Å:- Chain A: T.128, R.131, G.132, R.314
Ligand excluded by PLIPEDO.6: 7 residues within 4Å:- Chain A: I.160, L.190, G.191, Q.192, R.193, Y.214
- Ligands: EDO.7
Ligand excluded by PLIPEDO.7: 9 residues within 4Å:- Chain A: G.191, R.193, P.213, Y.214
- Chain B: P.155, S.158, L.190
- Ligands: EDO.6, EDO.8
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: P.213, Y.214, D.215, P.340, K.341
- Ligands: EDO.7
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: E.84, N.87, L.100, K.101, R.102, H.103
Ligand excluded by PLIPEDO.10: 2 residues within 4Å:- Chain A: R.297, I.302
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: Y.119, D.123, R.126, N.127
- Ligands: QS0.1
Ligand excluded by PLIPEDO.12: 3 residues within 4Å:- Chain A: H.99, K.101
- Ligands: EDO.13
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: K.101, R.102
- Ligands: EDO.12
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain A: Y.122, P.166, F.202, Y.203, E.229, P.235
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain A: Y.195, Q.196, Y.197
- Chain C: K.70
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain B: K.298, L.299, H.300, K.329
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain B: L.83, M.86, N.87, V.98, H.99, L.100
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain B: Q.196, Y.197, V.208, L.209, E.242, K.266
- Chain D: N.108
Ligand excluded by PLIPEDO.20: 2 residues within 4Å:- Chain B: K.67, F.72
Ligand excluded by PLIPEDO.22: 3 residues within 4Å:- Chain A: K.67
- Chain C: N.20, K.67
Ligand excluded by PLIPEDO.24: 8 residues within 4Å:- Chain C: L.83, M.86, N.87, K.94, I.97, V.98, H.99, L.100
Ligand excluded by PLIPEDO.25: 6 residues within 4Å:- Chain A: N.108
- Chain C: Q.196, Y.197, V.208, L.209, E.242
Ligand excluded by PLIPEDO.26: 8 residues within 4Å:- Chain C: I.160, Q.189, L.190, G.191, Q.192, R.193, Y.214
- Ligands: EDO.27
Ligand excluded by PLIPEDO.27: 8 residues within 4Å:- Chain C: G.191, R.193, P.213, Y.214
- Chain D: P.155, S.158, L.190
- Ligands: EDO.26
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain C: E.84, N.87, K.101, R.102, H.103
Ligand excluded by PLIPEDO.29: 2 residues within 4Å:- Chain C: K.94, H.99
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain C: R.334, I.344, Y.348
- Ligands: EDO.31
Ligand excluded by PLIPEDO.31: 7 residues within 4Å:- Chain C: R.334, T.342, R.343, I.344, Q.345, Y.348
- Ligands: EDO.30
Ligand excluded by PLIPEDO.33: 5 residues within 4Å:- Chain D: L.83, N.87, V.98, H.99, L.100
Ligand excluded by PLIPEDO.34: 5 residues within 4Å:- Chain D: V.252, K.298, L.299, H.300, K.329
Ligand excluded by PLIPEDO.35: 6 residues within 4Å:- Chain C: S.158, L.190
- Chain D: L.190, G.191, Q.192, R.193
Ligand excluded by PLIPEDO.36: 1 residues within 4Å:- Chain D: R.55
Ligand excluded by PLIPEDO.37: 2 residues within 4Å:- Chain D: Y.16, R.107
Ligand excluded by PLIP- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.21: 3 residues within 4Å:- Chain B: K.140, R.176, S.177
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.177
- Salt bridges: B:K.140, B:R.176
SO4.38: 3 residues within 4Å:- Chain D: K.140, R.176, S.177
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:S.177, D:S.177
- Salt bridges: D:K.140
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grygier, P. et al., Structural perspective on the design of selective DYRK1B inhibitors. To Be Published
- Release Date
- 2024-01-10
- Peptides
- Dual specificity tyrosine-phosphorylation-regulated kinase 1A: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x QS0: N-[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]-4-(1-methylpyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine
- 32 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grygier, P. et al., Structural perspective on the design of selective DYRK1B inhibitors. To Be Published
- Release Date
- 2024-01-10
- Peptides
- Dual specificity tyrosine-phosphorylation-regulated kinase 1A: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D